Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Translational Medicine|September 12, 2024
An artificial intelligence-based model exploiting H&E images to predict recurrence in negative sentinel lymph-node melanoma patientsMaria Colomba Comes, Livia Fucci, Sabino Strippoli, et al.
Frontiers in Oncology|November 25, 2021
Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From ItalySabino Strippoli, Annarita Fanizzi, Davide Quaresmini, et al.
Journal of Geriatric Oncology|January 14, 2020
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre studyLaura Ridolfi, Francesco De Rosa, Elisabetta Petracci, et al.
Frontiers in Medicine|November 11, 2024
Corrigendum: The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
Frontiers in Medicine|September 26, 2024
The molecular tumor board as a step in cancer patient management: a southern Italian experienceStefania Tommasi, Leonarda Maurmo, Alessandro Rizzo, et al.
Cancers|February 3, 2021
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) StudyMichele Guida, Nicola Bartolomeo, Pietro Quaglino, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 9, 2026
How should primary pulmonary sarcoma be staged? Results of an International Multicenter AnalysisTheresa Stork, Dagmar Adamkova, Clemens Aigner, et al.
JTCVS Open|December 31, 2025
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective studyStephane Collaud, Theresa Stork, Dagmar Adamkova, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profilePaolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.
Frontiers in Oncology|October 12, 2020
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on SurvivalFrancesco Mannavola, Mario Mandala, Annalisa Todisco, et al.
Pageof 6